Published in Hypertension on October 27, 2003
Pik Lenin High Altitude Research Expedition 2009 (PLHARE) | NCT01571687
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy | NCT04042298
Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect (2005) 3.14
Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2006) 3.13
Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol (2005) 2.88
Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol (2004) 2.46
Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med (2009) 2.24
Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res (2006) 1.89
NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol (2009) 1.80
Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling. Mol Biol Cell (2007) 1.60
Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic Biol Med (2011) 1.56
Endothelin activation of reactive oxygen species mediates stress-induced pressor response in Dahl salt-sensitive prehypertensive rats. Hypertension (2010) 1.49
Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol (2006) 1.35
Pulmonary oxidative stress, inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res Public Health (2013) 1.26
N-acetylcysteine -- passe-partout or much ado about nothing? Br J Clin Pharmacol (2006) 1.23
Early determinants of H2O2-induced endothelial dysfunction. Free Radic Biol Med (2006) 1.22
Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants. J Res Med Sci (2014) 1.20
P66Shc signals to age. Aging (Albany NY) (2009) 1.18
Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal (2010) 1.17
Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia. Am J Respir Crit Care Med (2009) 1.17
Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers (2013) 1.16
Oxidative stress impairs endothelial progenitor cell function. Antioxid Redox Signal (2008) 1.15
NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. Am J Physiol Heart Circ Physiol (2008) 1.14
The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress. Med Clin North Am (2009) 1.13
Exercise in the metabolic syndrome. Oxid Med Cell Longev (2012) 1.11
Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. Int J Clin Pract (2008) 1.10
Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status: benefits in type 2 diabetes mellitus. Oxid Med Cell Longev (2012) 1.06
Cyclophilin A: promising new target in cardiovascular therapy. Circ J (2010) 1.04
Essential hypertension and oxidative stress: New insights. World J Cardiol (2014) 1.04
Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complement Altern Med (2010) 1.04
Opposing actions of heat shock protein 90 and 70 regulate nicotinamide adenine dinucleotide phosphate oxidase stability and reactive oxygen species production. Arterioscler Thromb Vasc Biol (2012) 1.03
Effects of oxidative stress on mouse embryonic stem cell proliferation, apoptosis, senescence, and self-renewal. Stem Cells Dev (2010) 1.02
Diabetes and alpha lipoic Acid. Front Pharmacol (2011) 1.01
Contribution of oxidative stress to pulmonary arterial hypertension. World J Cardiol (2010) 1.00
The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol (2012) 1.00
Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J Pharmacol Exp Ther (2012) 0.99
The ClC-3 chloride channels in cardiovascular disease. Acta Pharmacol Sin (2011) 0.99
Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities. Int J Hypertens (2012) 0.97
Increased coronary vessel wall thickness in HIV-infected young adults. Clin Infect Dis (2014) 0.97
Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am (2013) 0.95
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. Pharmacol Rev (2015) 0.94
Mitochondrial apoptotic signaling is elevated in cardiac but not skeletal muscle in the obese Zucker rat and is reduced with aerobic exercise. J Appl Physiol (1985) (2008) 0.92
Subcellular localization of nicotinamide adenine dinucleotide phosphate oxidase subunits in neurons and astroglia of the rat medial nucleus tractus solitarius: relationship with tyrosine hydroxylase immunoreactive neurons. Neuroscience (2006) 0.92
Hepatic consequences of vascular adhesion protein-1 expression. J Neural Transm (Vienna) (2011) 0.92
Tempol, a superoxide dismutase mimetic, prevents cerebral vessel remodeling in hypertensive rats. Microvasc Res (2010) 0.89
Inhibition of human vascular NADPH oxidase by apocynin derived oligophenols. Bioorg Med Chem (2009) 0.89
Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress. Curr Cardiol Rev (2008) 0.88
Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts. PLoS One (2013) 0.88
Relationships between heart rate variability, vascular function, and adiposity in children. Clin Auton Res (2007) 0.88
Comparison of mechanisms involved in impaired vascular reactivity between high sucrose and high fat diets in rats. Nutr Metab (Lond) (2010) 0.87
ROS regulate cardiac function via a distinct paracrine mechanism. Cell Rep (2014) 0.87
Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species. Cardiovasc Res (2011) 0.87
Cyclophilin A is required for angiotensin II-induced p47phox translocation to caveolae in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2013) 0.87
Endothelial dysfunction and oxidant status in pediatric patients with hemoglobin E-beta thalassemia. Pediatr Cardiol (2007) 0.86
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease. Clin Exp Nephrol (2007) 0.86
Antioxidants in kidney diseases: the impact of bardoxolone methyl. Int J Nephrol (2012) 0.86
Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction. Am J Pathol (2010) 0.86
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury. Cardiovasc Diabetol (2014) 0.86
Reactive oxygen species cause endothelial dysfunction in chronic flow overload. J Appl Physiol (1985) (2010) 0.86
Oxidative stress-induced premature senescence in Wharton's jelly-derived mesenchymal stem cells. Int J Med Sci (2014) 0.86
Muscle sympathetic nerve activity is related to a surrogate marker of endothelial function in healthy individuals. PLoS One (2010) 0.85
Effect of single-session aerobic exercise with varying intensities on lipid peroxidation and muscle-damage markers in sedentary males. Glob J Health Sci (2012) 0.85
Changes in the subcellular distribution of NADPH oxidase subunit p47phox in dendrites of rat dorsomedial nucleus tractus solitarius neurons in response to chronic administration of hypertensive agents. Exp Neurol (2007) 0.84
Antioxidant and vasodilatory effects of heme oxygenase on mesenteric vasoreactivity following chronic hypoxia. Microcirculation (2008) 0.84
Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus. Redox Biol (2013) 0.84
Impaired flow-induced dilation of coronary arterioles of dogs fed a low-salt diet: roles of ANG II, PKC, and NAD(P)H oxidase. Am J Physiol Heart Circ Physiol (2010) 0.84
The beta1 subunit enhances oxidative regulation of large-conductance calcium-activated K+ channels. J Gen Physiol (2004) 0.83
Angiotensin II receptors and drug discovery in cardiovascular disease. Drug Discov Today (2010) 0.83
The role of the endogenous antioxidant enzymes and malondialdehyde in essential hypertension. J Clin Diagn Res (2013) 0.83
Effect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney disease. Am J Nephrol (2008) 0.83
High fat feeding impairs endothelin-1 mediated vasoconstriction through increased iNOS-derived nitric oxide. Horm Metab Res (2011) 0.83
Syringic acid ameliorates (L)-NAME-induced hypertension by reducing oxidative stress. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.82
Antioxidant and cytotoxic activity of hydroethanolic extract from Jacaranda decurrens leaves. PLoS One (2014) 0.82
The release of nitric oxide from S-nitrosothiols promotes angiogenesis. PLoS One (2006) 0.82
Renovascular hypertension leads to DNA damage and apoptosis in bone marrow cells. DNA Cell Biol (2013) 0.82
Sinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited rats. PLoS One (2014) 0.82
Porcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro. Tissue Eng Part A (2010) 0.82
Consumption of water containing over 3.5 mg of dissolved hydrogen could improve vascular endothelial function. Vasc Health Risk Manag (2014) 0.82
Lesions and lipids and radicals--O my! Tex Heart Inst J (2004) 0.81
Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am J Pathol (2006) 0.81
Superoxide dismutase analog (Tempol: 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine 1-oxyl) treatment restores erectile function in diabetes-induced impotence. Int J Impot Res (2009) 0.81
Regulation of thromboxane receptor signaling at multiple levels by oxidative stress-induced stabilization, relocation and enhanced responsiveness. PLoS One (2010) 0.81
Quantification of particle-induced inflammatory stress response: a novel approach for toxicity testing of earth materials. Geochem Trans (2012) 0.81
Interaction of TNF with angiotensin II contributes to mitochondrial oxidative stress and cardiac damage in rats. PLoS One (2012) 0.80
Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery. Br J Pharmacol (2009) 0.80
Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis. Br J Pharmacol (2011) 0.80
Study of the cardiotoxicity of Venenum Bufonis in rats using an 1H NMR-based metabolomics approach. PLoS One (2015) 0.80
A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-α activity. Int J Mol Med (2014) 0.80
Family with sequence similarity 5, member C (FAM5C) increases leukocyte adhesion molecules in vascular endothelial cells: implication in vascular inflammation. PLoS One (2014) 0.80
Losartan abolishes oxidative stress induced by intermittent hypoxia in humans. J Physiol (2011) 0.80
Critical role of mitochondrial ROS is dependent on their site of production on the electron transport chain in ischemic heart. Am J Cardiovasc Dis (2016) 0.79
Resveratrol inhibits phenotype modulation by platelet derived growth factor-bb in rat aortic smooth muscle cells. Oxid Med Cell Longev (2014) 0.79
Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension. Braz J Med Biol Res (2014) 0.79
Differential modulation of bradykinin-induced relaxation of endothelin-1 and phenylephrine contractions of rat aorta by antioxidants. Acta Pharmacol Sin (2007) 0.79
Inflammation and reactive oxygen species in cardiovascular disease. World J Cardiol (2010) 0.79
Regulation of thrombosis and vascular function by protein methionine oxidation. Blood (2015) 0.79
Benzo[a]pyrene potentiates the pathogenesis of abdominal aortic aneurysms in apolipoprotein E knockout mice. Cell Physiol Biochem (2012) 0.79
Combination therapy with losartan and pioglitazone additively reduces renal oxidative and nitrative stress induced by chronic high fat, sucrose, and sodium intake. Oxid Med Cell Longev (2012) 0.79
Reactive metabolites and antioxidant gene polymorphisms in type 2 diabetes mellitus. Indian J Hum Genet (2014) 0.79
Multiple Signaling Pathways Contribute to the Thrombin-induced Secretory Phenotype in Vascular Smooth Muscle Cells. Korean J Physiol Pharmacol (2015) 0.79
Altered vascular smooth muscle function in the ApoE knockout mouse during the progression of atherosclerosis. Atherosclerosis (2014) 0.79
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol (2006) 7.84
Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 4.56
Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation (2002) 3.95
Role of oxidative stress in atherosclerosis. Am J Cardiol (2003) 3.66
Nox proteins in signal transduction. Free Radic Biol Med (2009) 3.47
Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem (2004) 3.37
Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res (2002) 3.32
Measurement of reactive oxygen species in cardiovascular studies. Hypertension (2007) 3.17
Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol (2006) 3.13
The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci (2003) 3.13
Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation (2005) 3.12
Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler Thromb Vasc Biol (2002) 3.10
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov (2011) 3.08
Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res (2012) 3.02
Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res (2009) 2.83
NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol (2009) 2.83
Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med (2008) 2.68
Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) (2006) 2.24
NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol (2008) 2.22
Reactive oxygen species, mitochondria, and NAD(P)H oxidases in the development and progression of heart failure. Congest Heart Fail (2002) 2.18
Oscillatory shear stress stimulates endothelial production of O2- from p47phox-dependent NAD(P)H oxidases, leading to monocyte adhesion. J Biol Chem (2003) 2.09
Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med (2005) 2.05
Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol (2009) 2.01
Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res (2006) 1.89
Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med (2007) 1.81
Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst (2003) 1.73
NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal (2002) 1.64
Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. Am J Physiol Heart Circ Physiol (2007) 1.57
Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol (2004) 1.57
Reactive oxygen species in hypertension; An update. Am J Hypertens (2004) 1.56
Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling. Free Radic Biol Med (2011) 1.56
Redox signaling, vascular function, and hypertension. Antioxid Redox Signal (2008) 1.52
Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension (2005) 1.49
Role of the multidrug resistance protein-1 in hypertension and vascular dysfunction caused by angiotensin II. Arterioscler Thromb Vasc Biol (2007) 1.47
NADPH oxidase inhibitors: new antihypertensive agents? J Cardiovasc Pharmacol (2007) 1.44
Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J Biol Chem (2008) 1.43
RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension (2006) 1.41
Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4. Free Radic Biol Med (2005) 1.36
Functional association of nox1 with p22phox in vascular smooth muscle cells. Free Radic Biol Med (2004) 1.34
Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol (2010) 1.31
Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol (2004) 1.29
Nox5 mediates PDGF-induced proliferation in human aortic smooth muscle cells. Free Radic Biol Med (2008) 1.27
Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice. Am J Physiol Heart Circ Physiol (2004) 1.26
Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal (2013) 1.26
Career development of physician scientists: a survey of leaders in academic medicine. Am J Med (2011) 1.26
Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol (2004) 1.26
Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension (2010) 1.24
Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions. Mol Cell Biol (2003) 1.23
Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol (2005) 1.22
NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor. Free Radic Biol Med (2010) 1.18
Dual regulation of cofilin activity by LIM kinase and Slingshot-1L phosphatase controls platelet-derived growth factor-induced migration of human aortic smooth muscle cells. Circ Res (2007) 1.17
C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension (2004) 1.12
Stimulation of cellular signaling and G protein subunit dissociation by G protein betagamma subunit-binding peptides. J Biol Chem (2003) 1.12
Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products. Free Radic Biol Med (2007) 1.10
Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species. J Biol Chem (2003) 1.08
Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells. Mol Pharmacol (2002) 1.07
Redox control of vascular smooth muscle migration. Antioxid Redox Signal (2010) 1.06
Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle. Antioxid Redox Signal (2002) 1.06
Detection of reactive oxygen species and nitric oxide in vascular cells and tissues: comparison of sensitivity and specificity. Methods Mol Med (2007) 1.03
NADPH oxidases: new regulators of old functions. Antioxid Redox Signal (2006) 1.01
Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species. Atherosclerosis (2007) 0.99
Oxidative stress and diabetic vascular complications. Curr Diab Rep (2004) 0.96
Differential roles of NADPH oxidases in vascular physiology and pathophysiology. Front Biosci (Schol Ed) (2012) 0.95
NADPH oxidases: molecular understanding finally reaching the clinical level? Antioxid Redox Signal (2009) 0.93
Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2. Mol Pharmacol (2005) 0.91
Functional evaluation of nonphagocytic NAD(P)H oxidases. Methods Enzymol (2002) 0.91
Platelet-derived growth factor (PDGF) regulates Slingshot phosphatase activity via Nox1-dependent auto-dephosphorylation of serine 834 in vascular smooth muscle cells. J Biol Chem (2011) 0.88
The A640G and C242T p22(phox) polymorphisms in patients with coronary artery disease. Antioxid Redox Signal (2002) 0.88
Polymerase delta interacting protein 2 sustains vascular structure and function. Arterioscler Thromb Vasc Biol (2013) 0.87
Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2009) 0.87
Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9. J Vasc Res (2012) 0.87
Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol Pharmacol (2003) 0.85
Reactive oxygen species sensitivity of angiotensin II-dependent translation initiation in vascular smooth muscle cells. J Biol Chem (2003) 0.84
Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation. PLoS One (2013) 0.83
Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor. Exp Cell Res (2011) 0.83
Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association. Circ Res (2016) 0.83
Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK. Am J Physiol Cell Physiol (2011) 0.81
NADPH oxidases: progress and opportunities. Antioxid Redox Signal (2014) 0.81
Hydrogen peroxide regulates osteopontin expression through activation of transcriptional and translational pathways. J Biol Chem (2013) 0.81
The bone morphogenic protein inhibitor, noggin, reduces glycemia and vascular inflammation in db/db mice. Am J Physiol Heart Circ Physiol (2013) 0.79
Nox is playing with a full deck in vascular smooth muscle, a commentary on "Noxa1 is a central component of the smooth muscle NADPH oxidase in mice". Free Radic Biol Med (2006) 0.79
Mycophenolic acid is a new Nox2 inhibitor. Hypertension (2006) 0.77
Out phoxing the endothelium: what's left without p47? Circ Res (2002) 0.77
The yin/yang of superoxide dismutase mimetics: potential cardiovascular therapies? Br J Pharmacol (2003) 0.77
Redox control of growth factor signaling in heart, lung, and circulation. Antioxid Redox Signal (2003) 0.76
Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift. Circ Res (2014) 0.75
Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association. Circ Res (2017) 0.75
Notice of retraction. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001;21:489-95. Arterioscler Thromb Vasc Biol (2013) 0.75
Polymerase δ-interacting Protein 2: A Multifunctional Protein. J Cardiovasc Pharmacol (2017) 0.75